Sentences with phrase «reduce psychiatric symptoms»

on Oh, well — «love hormone» doesn't reduce psychiatric symptoms, say researchers in request to retract

At least, that's the conclusion the authors of a 2015 meta - analysis, which initially found intranasal doses of oxytocin could reduce psychiatric symptoms, have now reached.

It turns out, snorting the so - called «love hormone» may not help reduce psychiatric symptoms such as depression and anxiety.

First author Stefan Hofmann from Boston University in Massachusetts explains further in a lengthy letter he sent to Psychiatry Research, which he passed on to us: Continue reading Oh, well — «love hormone» doesn't reduce psychiatric symptoms, say researchers in request to retract

Oh, well — «love hormone» doesn't reduce psychiatric symptoms, say researchers in request to retract

Not exact matches

«One approach to managing tardive dyskinesia is to discontinue antipsychotic treatment or reduce the dosage, but these options are not always feasible, because withdrawal can exacerbate tardive dyskinesia symptoms or have a negative impact on psychiatric status.

But new research presented at the American Diabetes Association's 74th Scientific Sessions ® shows that symptoms of depression in people with type 2 diabetes can be significantly reduced through interventions for «diabetes distress,» suggesting that much of what is being labeled as depression may not be a co-morbid psychiatric disorder after all, but rather a reaction to living with a stressful, complex disease that is often difficult to manage.

«CBD may protect against psychiatric risk from high - THC cannabis strains: Neuroscientists find cannabidiol reduces symptoms such as impaired memory in adolescent mice simultaneously exposed to THC.»

Difficulties in recruiting and retaining BSA participants by 9 months reduced the sample size.59 Self - reported questionnaires indicate the presence of depressive symptoms, but given the absence of psychiatric interviews, this is not diagnostic of a depressive disorder.

Moreover, men with depressive symptoms have reduced parasympathetic activity compared with control subjects, whereas no differences between depressed women and controls have been reported.44) Because the demographic characteristics of patients with various psychiatric disorders (e.g., schizophrenia, bipolar disorder, PTSD, and MDD) differ, the recruitment of separate groups of healthy controls that are well matched to individuals with each psychiatric disorder is necessary to clarify the HRV data.

Several psychotherapy treatments specifically developed for patients with borderline personality disorder (BPD) have proven to be effective.1 General psychiatric management (GPM) is one of the therapies that have been shown to be effective for reducing recurrent suicidal and self - harm behaviour, symptom distress and borderline personality disorder features.2 However, these proven effective therapies1, 2 have generally been delivered over 1 — 3 years of therapy.

When prescribed appropriately by an experienced clinician and taken as directed, medication may reduce or eliminate troubling symptoms and improve daily functioning of children and adolescents with psychiatric disorders.

Results indicated that MST - CAN was significantly more effective than EOT in reducing youth mental health symptoms, parent psychiatric distress, parenting behaviors associated with maltreatment, youth out - of - home placements, and changes in youth placement.

Nevertheless a recent study (Gatta et al., 2016b), aiming to examine the usefulness of the LTP as an outcome measure, found that the LTP assessment of the family interactions might help clinicians to focus on the dysfunctional familial dynamics, thus improving the effectiveness of a video - feedback intervention with the families of children and adolescents with psychiatric disorders (i.e., significantly reducing internalizing symptoms).

Indeed, mindfulness - based programs reduce stress in healthy adults (Chiesa and Serretti 2009), and reduce stress, anxiety, and depressive symptoms in adults with various psychiatric or medical conditions (Gotink et al. 2015; Hofmann et al. 2010).